Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,126.00    -32.00 (-1.48%)
Bid:
2,130.00
Ask:
2,136.00
Spread: 6.00 (0.282%)
Market Cap: £1.41b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

22 Sep 2010 14:49

RNS Number : 1319T
Genus PLC
22 September 2010
Β 

22 September 2010

Β 

Genus plc

Β 

('Genus' or 'the Company')

Β 

Director/PDMR Shareholding

Β 

Β 

Genus announces that conditional nil-cost share options were granted under the Genus 2004 Performance Share PlanΒ ("the Plan")Β todayΒ toΒ Richard Wood, Chief Executive, as toΒ 57,631 ordinaryΒ sharesΒ of 10 pence each in theΒ CompanyΒ ("Ordinary Shares"). These options are subject to performance conditions which relate to growth in the Company's earnings per share over a three year period and which trigger vesting on an incremental basis.

Β 

Genus further announces that of 154,639 Ordinary Shares that vested today in favour of Richard Wood, Chief Executive, under the Plan, 154,639 Ordinary Shares were today sold on behalf of Richard Wood at a price ofΒ 770Β pence per Ordinary Share.

Β 

Richard Wood's direct shareholding in the Company stands atΒ 60,856Β Ordinary Shares which representsΒ 0.102%Β of the issued share capital of the Company which is currentlyΒ 59,678,535 Ordinary Shares. In addition, he remains the beneficial owner of 195,457 conditional nil-cost optionsΒ under the Plan.

Β 

Genus also announces that ofΒ 34,364Β Ordinary SharesΒ that vested today in favour of Ian Biggs, Head of Global Product & Business Strategy, under the Plan,Β 34,364Β Ordinary Shares were today sold on behalf ofΒ Ian BiggsΒ at a price ofΒ 770Β pence per Ordinary Share. Ian Biggs'Β direct shareholding in the Company stands atΒ 3,375Β Ordinary Shares which representsΒ 0.006%Β of the issued share capital of the Company. In addition, he remains the beneficial owner ofΒ 109,530Β conditional nil-cost optionsΒ under the Plan.

Β 

OfΒ 33,505Β Ordinary Shares that vested today in favour of Thomas Philip Acton, Chief Operating Officer of Europe & The Far East, under the Plan, 33,505Β Ordinary Shares were today sold on behalf of Thomas Philip Acton at a price ofΒ 770Β pence per Ordinary Share.

Thomas Philip Acton'sΒ direct shareholding in the Company stands atΒ 21,104Β Ordinary Shares which representsΒ 0.035%Β of the issued share capital of the Company. In addition, he remains the beneficial owner of 103,084 conditional nil-cost optionsΒ under the Plan.

Β 

Of 17,182 Ordinary Shares that vested today in favour of Ian Farrelly, Group Company Secretary & General Counsel, under the Plan, 17,182 Ordinary Shares were today sold on behalf of Ian Farrelly at a price ofΒ 770Β pence per Ordinary Share. Ian Farrelly has no direct shareholding in the Company. He remains the beneficial owner of 75,018 conditional nil-cost optionsΒ under the Plan.

Β 

Β 

For further information please contact:

Β 

Cara Crichton

Company Secretarial Assistant

Genus plc

Β 

Tel: 01256 345996

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSUUSORRWAKUAR
Date   Source Headline
8th Mar 20223:47 pmRNSNotification of Major Holdings
8th Mar 20221:13 pmRNSNotification of Major Holdings
24th Feb 20227:00 amRNSCollaboration between PIC and Olymel LP in Canada
24th Feb 20227:00 amRNSInterim Results
1st Feb 20224:57 pmRNSBlock listing Interim Review
4th Jan 20229:47 amRNSTotal Voting Rights
26th Nov 202110:18 amRNSDisclosure of Rights Attached to Equity Shares
24th Nov 20215:51 pmRNSDirector/PDMR Shareholding
24th Nov 20212:47 pmRNSResult of AGM
24th Nov 20212:30 pmRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSAGM Trading Update
10th Nov 20212:28 pmRNSNotification of Major Holdings
15th Oct 20217:00 amRNSAnnual Report and Annual General Meeting
13th Oct 20215:56 pmRNSDirector/PDMR Shareholding
1st Oct 20213:58 pmRNSTotal Voting Rights
30th Sep 20219:59 amRNSDirector Declaration
29th Sep 20212:59 pmRNSNotification of Major Holdings
15th Sep 20214:45 pmRNSDirector/PDMR Shareholding
14th Sep 20214:32 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSPreliminary Results
1st Sep 20212:05 pmRNSTotal Voting Rights
2nd Aug 20214:00 pmRNSBlock listing Interim Review
2nd Aug 202110:09 amRNSTotal Voting Rights
1st Jul 20214:39 pmRNSTotal Voting Rights
28th Jun 20215:00 pmRNSPIC AND SERGAL ENTER INTO STRATEGIC RELATIONSHIP
22nd Jun 20217:00 amRNSCapital Markets Event & PRRSv Programme Update
14th Jun 20213:01 pmRNSNotification of Major Holdings
7th Jun 202110:42 amRNSApplication For Additional Listing
4th Jun 20214:38 pmRNSNotification of Major Holdings
17th May 20211:23 pmRNSNotification of Major Holdings
13th May 202110:50 amRNSDirector/PDMR Shareholding
9th Apr 20214:10 pmRNSDirector/PDMR Shareholding
6th Apr 20216:00 pmRNSDirector/PDMR Shareholding
1st Apr 20215:49 pmRNSTotal Voting Rights
31st Mar 20212:59 pmRNSDirector/PDMR Shareholding
22nd Mar 20217:00 amRNSBoard Changes
19th Mar 202112:20 pmRNSDirector/PDMR Shareholding
9th Mar 20215:41 pmRNSNotification of Major Holdings
3rd Mar 20215:19 pmRNSDirector/PDMR Shareholding
26th Feb 202112:39 pmRNSDirector/PDMR Shareholding
25th Feb 20217:00 amRNSInterim Results
1st Feb 202111:08 amRNSBlock listing Interim Review
1st Feb 202111:08 amRNSTotal Voting Rights
18th Jan 20217:00 amRNSTrading Update
2nd Dec 20205:44 pmRNSDirector/PDMR Shareholding
25th Nov 20201:13 pmRNSResult of AGM
25th Nov 20207:00 amRNSAGM Trading Update - Strong Performance Continues
11th Nov 20201:03 pmRNSNOTIFICATION OF MAJOR HOLDINGS
16th Oct 20208:00 amRNSAnnual Report and Annual General Meeting
1st Oct 20203:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.